D3 Bio

D3 Bio is a global biotechnology company dedicated to developing and commercializing disruptive precision therapeutics to improve or replace existing standard-of-care treatments in oncology and immunology that fail to fully meet significant clinical needs. D3 Bio collaborates with world-class partners worldwide, integrating profound clinical and market insights with disruptive technologies through an iterative cycle of development, discovery, and further development.